Objective: To evaluate the quality of life (QOL) of patients with breast cancer undergoing radiotherapy treatment. Methods: The current study is a descriptive quantitative approach that seeks to identify the QOL of breast cancer patients during their radiotherapy treatment. A convenience sample of 30 women undergoing radiotherapy for breast cancer completed the EORTC QLQC30 questionnaire on Day 1 and Day 28. Results: Results showed significant differences in QOL between the two sessions. Decreases in overall health (88.33 to 61.67) and functional health (76.45 to 67.77) were noted in parallel to an increase in the scale of symptoms (13.85 for 24.62). Conclusions: The radiotherapeutic treatment impacts the QOL of patients with breast cancer. It is crucial for the nursing team to work together with a multi-professional team to adequately manage the treatment of these patients adequately.
Objective: To evaluate the quality of life (QOL) of patients with breast cancer undergoing radiotherapy treatment. Methods: The current study is a descriptive quantitative approach that seeks to identify the QOL of breast cancer patients during their radiotherapy treatment. A convenience sample of 30 women undergoing radiotherapy for breast cancer completed the EORTC QLQC30 questionnaire on Day 1 and Day 28. Results: Results showed significant differences in QOL between the two sessions. Decreases in overall health (88.33 to 61.67) and functional health (76.45 to 67.77) were noted in parallel to an increase in the scale of symptoms (13.85 for 24.62). Conclusions: The radiotherapeutic treatment impacts the QOL of patients with breast cancer. It is crucial for the nursing team to work together with a multi-professional team to adequately manage the treatment of these patients adequately.
Authors: Daniela Dornelles Rosa; José Bines; Gustavo Werutsky; Carlos Henrique Barrios; Eduardo Cronemberger; Geraldo Silva Queiroz; Vladmir C Cordeiro de Lima; Ruffo Freitas-Júnior; José d'Oliveira Couto; Karla Emerenciano; Heloísa Resende; Susane Crocamo; Tomás Reinert; Brigitte Van Eyil; Yeni Nerón; Vanessa Dybal; Nicolas Lazaretti; Rita de Cassia Costamilan; Diocésio Alves Pinto de Andrade; Clarissa Mathias; Giovana Zerwes Vacaro; Giuliano Borges; Alessandra Morelle; Maira Caleffi; Carlos Sampaio Filho; Max S Mano; Facundo Zaffaroni; Rafaela Gomes de Jesus; Sergio Daniel Simon Journal: Breast Cancer Res Treat Date: 2020-07-29 Impact factor: 4.872
Authors: Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2018-09-12 Impact factor: 508.702
Authors: Adrian Murray Brunt; Joanne S Haviland; Mark Sydenham; Rajiv K Agrawal; Hafiz Algurafi; Abdulla Alhasso; Peter Barrett-Lee; Peter Bliss; David Bloomfield; Joanna Bowen; Ellen Donovan; Andy Goodman; Adrian Harnett; Martin Hogg; Sri Kumar; Helen Passant; Mary Quigley; Liz Sherwin; Alan Stewart; Isabel Syndikus; Jean Tremlett; Yat Tsang; Karen Venables; Duncan Wheatley; Judith M Bliss; John R Yarnold Journal: J Clin Oncol Date: 2020-07-14 Impact factor: 44.544
Authors: Adrian Murray Brunt; Joanne S Haviland; Duncan A Wheatley; Mark A Sydenham; Abdulla Alhasso; David J Bloomfield; Charlie Chan; Mark Churn; Susan Cleator; Charlotte E Coles; Andrew Goodman; Adrian Harnett; Penelope Hopwood; Anna M Kirby; Cliona C Kirwan; Carolyn Morris; Zohal Nabi; Elinor Sawyer; Navita Somaiah; Liba Stones; Isabel Syndikus; Judith M Bliss; John R Yarnold Journal: Lancet Date: 2020-04-28 Impact factor: 202.731